Menu

Sumitomo is the 32nd pharmaceutical manufacturer to place restrictions on 340B drug shipment in the contract pharmacy setting.

Sumitomo Is Thirty-Second Company to Implement Contract Pharmacy Restrictions

April 2, 2024 Rich Daly, Editor in Chief 340B Report Views

Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly

Astellas Adds Second Drug to 340B Contract Pharmacy Restrictions

Four More Drugmakers to End 340B Contract Pharmacy Restrictions in Arkansas Following Appeals Court Decision